Intronic <i>TP53</i> Polymorphisms Are Associated with Increased <i>Δ133TP53</i> Transcript, Immune Infiltration and Cancer Risk

Intronic <i>TP53</i> Polymorphisms Are Associated with Increased <i>Δ133TP53</i> Transcript, Immune Infiltration and Cancer Risk

We investigated the influence of selected <i>TP53</i> SNPs in exon 4 and intron 4 on cancer risk, clinicopathological features and expression of <i>TP53</i> isoforms. The intron 4 SNPs were significantly over-represented in cohorts of mixed cancers compared to three ethnicall...

Full description

Bibliographic Details
Main Authors:	Ramona A. Eiholzer, Sunali Mehta, Marina Kazantseva, Catherine J. Drummond, Cushla McKinney, Katie Young, David Slater, Brianna C. Morten, Kelly A. Avery-Kiejda, Annette Lasham, Nicholas Fleming, Helen R. Morrin, Karen Reader, Janice A. Royds, Michael Landmann, Simone Petrich, Roger Reddel, Lily Huschtscha, Ahmad Taha, Noelyn A. Hung, Tania L. Slatter, Antony W. Braithwaite
Format:	Article
Language:	English
Published:	MDPI AG 2020-09-01
Series:	Cancers
Subjects:	single nucleotide polymorphism <i>TP53</i> glioblastoma prostate cancer Δ133p53 rs1042522
Online Access:	https://www.mdpi.com/2072-6694/12/9/2472

Similar Items

TP53 rs1042522 polymorphism and early-onset breast cancer
by: Irmak Icen-Taskin, et al.
Published: (2020-01-01)

Association of polymorphism <i>TP53</i> Arg72Pro with radon-induced lung cancer in the Kazakh population
by: O. Bulgakova, et al.
Published: (2019-08-01)

p53 Dysregulation in Breast Cancer: Insights on Mutations in the <i>TP53</i> Network and p53 Isoform Expression
by: Luiza Steffens Reinhardt, et al.
Published: (2023-06-01)

Accessing a New Dimension in TP53 Biology: Multiplex Long Amplicon Digital PCR to Specifically Detect and Quantitate Individual <i>TP53</i> Transcripts
by: Annette Lasham, et al.
Published: (2020-03-01)

Breast Cancer Patient Prognosis Is Determined by the Interplay between <i>TP53</i> Mutation and Alternative Transcript Expression: Insights from <i>TP53</i> Long Amplicon Digital PCR Assays
by: Annette Lasham, et al.
Published: (2021-03-01)

The TP53 fertility network
by: Diego d'Avila Paskulin, et al.
Published: (2012-01-01)

The association of TP53 (Arg72Pro) rs1042522 C>G polymorphism and colorectal cancer susceptibility in Duhok individuals
by: Najat Taher Mahmood ,Dilan Jasim Khalil ,Salar Saadi Hussain ,Ibrahim Hasan Mustafa ,Farida Fariq Nerweyi
Published: (2023-08-01)

The cell cycle regulatory gene polymorphisms TP53 (rs1042522) and MDM2 (rs2279744) in lung cancer: a meta-analysis
by: O. Bulgakova, et al.
Published: (2020-12-01)

Mesonephric Adenocarcinoma of the Vagina Harboring <i>TP53</i> Mutation
by: Hyunjee Lee, et al.
Published: (2022-01-01)

Inhibition of <i>TP53</i> Mutant Oral Cancer by Reactivating p53
by: Yei-Jin Kang, et al.
Published: (2022-06-01)

The Association between Single Nucleotide Polymorphisms rs1042522 and rs1642785 in the TP53 gene and Acute Myeloid leukemia in a sample of the Baghdad/ Iraq population
by: Hadeel Hameed Dawood, et al.
Published: (2024-03-01)

p53/<i>TP53</i> Status Assessment in Gastroesophageal Adenocarcinoma
by: Elisa Boldrin, et al.
Published: (2023-05-01)

Exploring the Functions of Mutant p53 through <i>TP53</i> Knockout in HaCaT Keratinocytes
by: Daniil Romashin, et al.
Published: (2024-02-01)

Comprehensive Identification of Deleterious <i>TP53</i> Missense VUS Variants Based on Their Impact on TP53 Structural Stability
by: Benjamin Tam, et al.
Published: (2021-10-01)

Are We Moving the Needle for Patients with <i>TP53</i>-Mutated Acute Myeloid Leukemia?
by: Rory M. Shallis, et al.
Published: (2022-05-01)

<i>TP53</i> Abnormalities and MMR Preservation in 5 Cases of Proliferating Trichilemmal Tumours
by: Raquel Martín-Sanz, et al.
Published: (2021-05-01)

<i>TP53</i> in Myelodysplastic Syndromes: Recent Biological and Clinical Findings
by: Cosimo Cumbo, et al.
Published: (2020-05-01)

<i>TP53</i> Combined Phenotype Score Is Associated with the Clinical Outcome of <i>TP53</i>-Mutated Myelodysplastic Syndromes
by: Mariko Yabe, et al.
Published: (2021-11-01)

Somatic intronic TP53 c.375+5G mutations are a recurrent but under‐recognized mode of TP53 inactivation
by: M Herman Chui, et al.
Published: (2022-01-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)

<i>TP53</i> Gene Therapy as a Potential Treatment for Patients with COVID-19
by: Joe B. Harford, et al.
Published: (2022-03-01)

The Current Understanding of and Treatment Paradigm for Newly-Diagnosed <i>TP53</i>-Mutated Acute Myeloid Leukemia
by: Rory M. Shallis, et al.
Published: (2021-12-01)

TP53 GENE MUTATIONS – FROM GUARDIAN OF THE GENOME TO ONCOGENE
by: Petar Babović, et al.
Published: (2010-03-01)

<i>TP53</i> Expression and Mutational Analysis in Hematological Malignancy in Jeddah, Saudi Arabia
by: Heba Alkhatabi, et al.
Published: (2022-03-01)

Effects of the Mutant TP53 Reactivator APR-246 on Therapeutic Sensitivity of Pancreatic Cancer Cells in the Presence and Absence of WT-TP53
by: Stephen L. Abrams, et al.
Published: (2022-02-01)

Integrative Analysis of the Role of <i>TP53</i> in Human Pan-Cancer
by: Tingting Liu, et al.
Published: (2023-11-01)

Prognosis, Biology, and Targeting of <i>TP53</i> Dysregulation in Multiple Myeloma
by: Erin Flynt, et al.
Published: (2020-01-01)

TP53-Deficient Angiosarcoma Expression Profiling in Rat Model
by: Urszula Smyczyńska, et al.
Published: (2020-06-01)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
by: You-Na Sung, et al.
Published: (2022-12-01)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
by: Paola Monti, et al.
Published: (2020-10-01)

TP-0903 Is Active in Preclinical Models of Acute Myeloid Leukemia with <i>TP53</i> Mutation/Deletion
by: Eric D. Eisenmann, et al.
Published: (2022-12-01)

<i>TP53</i> Mutation in Acute Myeloid Leukemia: An Old Foe Revisited
by: Dong-Yeop Shin
Published: (2023-09-01)

A Missense Variant in <i>TP53</i> Could Be a Genetic Biomarker Associated with Bone Tissue Alterations
by: Ricardo Usategui-Martín, et al.
Published: (2024-01-01)

Imunorreatividade da p53 associada à ausência de mutações no gene TP53 em linfomas caninos Immunostaing of p53 associated with absence of mutations in TP53 gene in dogs with lymphoma
by: Sabryna Gouveia Calazans, et al.
Published: (2010-06-01)

TP53 and TP53-associated genes are correlated with the prognosis of paediatric neuroblastoma
by: Haiwei Wang, et al.
Published: (2022-06-01)

Whole-Body MRI Surveillance—Baseline Findings in the Swedish Multicentre Hereditary <i>TP53</i>-Related Cancer Syndrome Study (SWEP53)
by: Meis Omran, et al.
Published: (2022-01-01)

<i>TP53</i> Mutant Acute Myeloid Leukemia: The Immune and Metabolic Perspective
by: Federico Zingarelli, et al.
Published: (2022-11-01)

The <i>TP53</i> Codon 72 Arginine Polymorphism Is Found with Increased <i>TP53</i> Somatic Mutations in HPV(−) and in an Increased Percentage among HPV(+) Norwegian HNSCC Patients
by: Svein Erik Moe, et al.
Published: (2023-06-01)

Association of p53 codon 72 polymorphism with weight and metabolic diseases in a Central Indian population
by: Jessy Abraham, et al.
Published: (2024-01-01)

TP53 in Myelodysplastic Syndromes
by: Yan Jiang, et al.
Published: (2021-10-01)